Lukasz Partyka

Lukasz Partyka

Auto-generated profile, based on publicly available information

Lukasz Partyka

Angio-Medicus Angiology Clinic, Department of Angiology, Jagiellonian University School of Medicine, Krakow, Poland

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Journal of Vascular Surgery: Venous and Lymphatic Disorders
Verified
Journal Article
Closed access
MKMarek Krzanowski
Marek Krzanowski
LPLukasz Partyka
Lukasz Partyka
LDLukasz Drelicharz
Lukasz Drelicharz
MMMalgorzata Mielnik
Malgorzata Mielnik
MFMarzena Frolow
Marzena Frolow
TATomasz Aleksiejew-Kleszczynski
Tomasz Aleksiejew-Kleszczynski

1 May 2019 in Environmental Research
Verified
Journal Article
Closed access
IGIwona Gregorczyk-Maga
Iwona Gregorczyk-Maga
MMMikołaj Maga
Mikołaj Maga
AWAgnieszka Wachsmann
Agnieszka Wachsmann
MJMaciej K. Janik
Maciej K. Janik
OCOlga Chrzastek-Janik
Olga Chrzastek-Janik
MKMateusz Koziej
Mateusz Koziej

10 January 2004 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
MMMalgorzata Malczewska-Malec
Malgorzata Malczewska-Malec
IWIwona Wybranska
Iwona Wybranska
ILIwona Leszczynska-Golabek
Iwona Leszczynska-Golabek
LPLukasz Partyka
Lukasz Partyka
JHJadwiga Hartwich
Jadwiga Hartwich
ADAldona Dembinska-Kiec
Aldona Dembinska-Kiec
This study analyzes the relationship between risk factors related to overweight/obesity, insulin resistance, lipid tolerance, hypertension, endothelial function and genetic polymorphisms associated with: i) appetite regulation (leptin, melanocortin-3-receptor (MCR-3), dopamine receptor 2 (D2R)); ii) adipocyte differentiation and insulin sensitivity (peroxisome proliferator-activated receptor-γThe 122 members of 40 obese Caucasian families from southern Poland participated in the study. The genotypes were analyzed by restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR) or by direct sequencing. Phenotypes related to obesity (body mass index (BMI), fat/lean body mass composition, waist-to-hip ratio (WHR)), fasting lipids, glucose, leptin and insulin, as well as insulin during oral glucose tolerance test (OGTT) (4 points within 2 hours) and during oral lipid tolerance test (OLTT) (5 points within 8 hours) were assessed. The insulin sensitivity indexes: homeostasis model assessment of insulin resistance, whole body insulin sensitivity index, hepatic insulin sensitivity and early secretory response to an oral glucose load (HOMA-IR, ISI-COMP, ISI-HOMA and DELTA) were calculated.The single gene mutations such as CWe conclude that the polymorphisms we investigated were weakly correlated with obesity but significantly modified the risk factors of the metabolic syndrome.

1 January 2020 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
MKMarek Krzanowski
Marek Krzanowski
LPLukasz Partyka
Lukasz Partyka

13 October 2016 in BioMed Research International
Verified
Journal Article
Open access
PDF file
PMPaweł Maga
Paweł Maga
TMTomasz Mikolajczyk
Tomasz Mikolajczyk
LPLukasz Partyka
Lukasz Partyka
MKMarek Krzanowski
Marek Krzanowski
KMKrzysztof Piotr Malinowski
Krzysztof Piotr Malinowski
RNRafal Nizankowski
Rafal Nizankowski
Monocytes are mononuclear cells characterized by distinct morphology and expression of CD14 and CD16 surface receptors. Classical, quiescent monocytes are positive for CD14 (lipopolysaccharide receptor) but do not express Fc gamma receptor III (CD16). Intermediate monocytes coexpress CD16 and CD14. Nonclassical monocytes with low expression of CD14 represent mature macrophage-like monocytes. Monocyte behavior in peripheral arterial disease (PAD) and during vessel wall directed treatment is not well defined. This observation study aimed at monitoring of acute changes in monocyte subpopulations during percutaneous transluminal angioplasty (PTA) in PAD patients. Patients with Rutherford 3 and 4 PAD with no signs of inflammatory process underwent PTA of iliac, femoral, or popliteal segments. Flow cytometry for CD14, CD16, HLA-DR, CD11b, CD11c, and CD45RA antigens allowed characterization of monocyte subpopulations in blood sampled before and after PTA (direct angioplasty catheter sampling). Patients were clinically followed up for 12 months. All 61 enrolled patients completed 12-month follow-up. Target vessel failure occurred in 12 patients. While absolute counts of monocyte were significantly lower after PTA, only subtle monocyte activation after PTA (CD45RA andβ-integrins) occurred. None of the monocyte parameters correlated with long-term adverse clinical outcome. Changes in absolute monocyte counts and subtle changes towards an activation phenotype after PTA may reflect local cell adhesion phenomenon in patients with Rutherford 3 or 4 peripheral arterial disease.

10 November 2015 in Circulation
Verified
Journal Article
Closed access
TRTomasz Roleder
Tomasz Roleder
MSMariusz Skowerski
Mariusz Skowerski
AWAndrzej Więcek
Andrzej Więcek
MAMarcin Adamczak
Marcin Adamczak
BCBeata Czerwienska
Beata Czerwienska
WWWojtek Wojakowski
Wojtek Wojakowski
Intoduction: Although radiofrequency renal denervation (RF-RND) may cause acute spasm, intimal injury and thrombus formation, there are no data on long-term renal artery (RA) healing. Hypothesis: Aim of this study was to assess the RA healing after RF-RND by optical coherence tomography (OCT) imaging and quantitative contrast angiography (QCA) at long-term follow-up. Methods: A single center registry enrolled 12 patients (22 RA) with refractory hypertension previously treated with RF-RND (Symplicity, Medtronic). Imaging studies (QCA and OCT) were done at (mean±SD) 18.41±5.83 months after RF-RND. Results: No adverse events or complications were noted during the follow-up. Ten patients (83%) achieved significant reductions of blood pressure by ≥10 mmHg on 4.50 ± 1.08 medications per patient. OCT analysis involved 518 mm of pullbacks and 518 cross-sections. There were 26 spots of focal intimal thickening found in 10 (83%) patients in 14 (64%) arteries and calcifications in 2 (9%) of treated RA. The mean area of focal intimal thickening was 0.054±0.033 mm2 and it was limited to the intimal layer. No vessel dissection, thrombus, intimal tear or acute vasospasms were observed during the OCT analysis. The QCA revealed that minimal lumen and proximal lumen diameter were smaller after the RND and this difference was persistent at follow-up, as compared to measurements obtained before RND [6.21±1.01 vs. 5.61 ± 0.60, p=0.005 and 5.53±0.99 vs. 5.15±0.67, p=0.034, respectively]. Conclusions: There is a favorable long-term vessel healing after RF-RND without significant RA stenosis. Only focal intimal thickening and a modest reduction of the minimal lumen diameter may be observed in long-term and their relation to the RND procedure needs further studies.